This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—In a report of a "Sudden Death Following the Intravenous Injection of Bismuth Tartrate," by Dr. Stephen H. Curtis of Troy, N. Y. (The Journal, November 22, p. 1588) there appear a few mistakes that are liable to cause considerable confusion. In the second sentence of the fourth paragraph on page 1589, the word "suspended" should be changed to "dissolved." The name "Bismuth Tartrate" throughout this report should probably be replaced by "Sodium Bismuth Tartrate." To my knowledge, a product designated "Bismuth Tartrate" is insoluble in water.Unless such corrections are made, the value of the article is lessened.Incidentally, this article relates to a death following the intravenous injection of a bismuth compound. I have always been opposed to the employment of bismuth products intravenously, owing to their high toxicity by this route.
—On receipt of the letter from Dr. Raiziss, inquiry was made of
Raiziss GW. SUDDEN DEATH AFTER INTRAVENOUS USE OF BISMUTH TARTRATE. JAMA. 1931;96(3):211–212. doi:10.1001/jama.1931.02720290055028
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: